相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Angiogenesis in cancer Basic mechanisms and therapeutic advances
G. W. Prager et al.
HAMOSTASEOLOGIE (2012)
F-18-FDG PET/CT Imaging In Oncology
Ahmad Almuhaideb et al.
ANNALS OF SAUDI MEDICINE (2011)
Comparison Study of [18F]FAI-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET Imaging of U87MG Tumors in Mice
Lixin Lang et al.
BIOCONJUGATE CHEMISTRY (2011)
Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumors
Haruyasu Murakami et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Phase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid tumors
Yutaka Ueda et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products
O. Wahl et al.
CURRENT MEDICINAL CHEMISTRY (2011)
PET imaging of early response to the tyrosine kinase inhibitor ZD4190
Min Yang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
F-18-FPPRGD2 and F-18-FDG PET of Response to Abraxane Therapy
Xilin Sun et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled αvβ3-Integrin and αvβ5-Integrin Imaging Agent
Mark R. Battle et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4
Zhao-Hui Jin et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Science to Practice: Pilot Study of FPPRGD2 for Imaging αvβ3Integrin—How Integral Are Integrins?
Peter L. Choyke
RADIOLOGY (2011)
Pilot Pharmacokinetic and Dosimetric Studies of 18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3 Integrin Levels
Erik S. Mittra et al.
RADIOLOGY (2011)
PET Imaging of Integrin alpha V beta 3 Expression
Ambros J. Beer et al.
THERANOSTICS (2011)
Angiogenesis Imaging in Neoplasia
David J. Bowden et al.
JOURNAL OF CLINICAL IMAGING SCIENCE (2011)
RGD-cyclam conjugate: Synthesis and potential application for positron emission tomography
Mathieu Galibert et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
Erik Vegt et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
18F-Labeled Galacto and PEGylated RGD Dimers for PET Imaging of αvβ3 Integrin Expression
Shuanglong Liu et al.
MOLECULAR IMAGING AND BIOLOGY (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Noninvasive Imaging of αVβ3 Function as a Predictor of the Antimigratory and Antiproliferative Effects of Dasatinib
Rebecca A. Dumont et al.
CANCER RESEARCH (2009)
Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours
Marleen Melis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Application of RGD-containing peptides as imaging probes for alphavbeta3 expression
Ingrid Dijkgraaf et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Use of a Novel Arg-Gly-Asp Radioligand, F-18-AH111585, to Determine Changes in Tumor Vascularity After Antitumor Therapy
Matthew S. Morrison et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Clustering and Internalization of Integrin αvβ3 With a Tetrameric RGD-synthetic Peptide
Lucie Sancey et al.
MOLECULAR THERAPY (2009)
Chemical and Biological Evaluations of an 111In-Labeled RGD-Peptide Targeting Integrin Alpha(V) Beta(3) in a Preclinical Tumor Model
Mitra Ahmadi et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients
Laura M. Kenny et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Specific Expression of Endoglin (CD105) in Endothelial Cells of Intratumoral Blood and Lymphatic Vessels in Pancreatic Cancer
Hideyuki Yoshitomi et al.
PANCREAS (2008)
In vivo imaging of tumour angiogenesis in mice with the αvβ3 integrin-targeted tracer 99mTc-RAFT-RGD
Lucie Sancey et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
In vivo optical imaging of integrin αv-β3 in mice using multivalent or monovalent cRGD targeting vectors
Zhao-Hui Jin et al.
MOLECULAR CANCER (2007)
αvβ3-integrin imaging:: a new approach to characterise angiogenesis?
Roland Haubner
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Noninvasive visualization of the activated αvβ3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD
R Haubner et al.
PLOS MEDICINE (2005)
Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis
D Boturyn et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Molecular imaging in drug discovery and development
M Rudin et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Translating angiogenesis research into the clinic: the challenges ahead
HG Augustin
BRITISH JOURNAL OF RADIOLOGY (2003)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
分享论文
